Patient- and provider-reported adherencetoward a clinically useful approach to measuring antiretroviral adherence

Journal of Clinical Epidemiology

Volumn 54, Issue 12 SUPPL. 1, 2001, Pages

  Wagner, J H ^a,b   Justice, A C ^a,b   Chesney, M ^c   Sinclair, G ^d   Weissman, S ^e   Rodriguez Barradas, M ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adherence; Alcohol use; AUDIT; CESD 10; Depressive symptoms; Drug use; HIV; HIV 1 viral load; Homelessness

Indexed keywords

ANTIRETROVIRUS AGENT;

ALCOHOL CONSUMPTION; CONFERENCE PAPER; DEPRESSION; DRUG USE; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL AUDIT; PATIENT COMPLIANCE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; VIRUS LOAD; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LONGITUDINAL STUDY; MULTICENTER STUDY; NONPARAMETRIC TEST; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; SELF EVALUATION; SOLDIER; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; COMPARATIVE STUDY; HIV INFECTIONS; HIV-1; HUMAN; LONGITUDINAL STUDIES; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; REGRESSION ANALYSIS; SELF ASSESSMENT (PSYCHOLOGY); STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; VETERANS; VIRAL LOAD;

EID: 0035665765     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00450-4     Document Type: Conference Paper

References (45)

1. Antiretroviral therapy; factors associated with adherence
2. HIV-1 protease inhibitors. A review for clinicians
3. Compliance in clinical trials
4. Adherence in AIDS clinical trials; a framework for clinical research and clinical care
5. Compliance declines between clinic visits
6. Concurrent and predictive validity of a self-reported measure of medication adherence
7. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group
8. Understanding and improving patient compliance
9. Adherence; a necessity for successful HIV combination therapy
10. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens
11. Time to stop counting the tablets?
12. The natural history of medication compliance in a drug trial; limitations of pill counts
13. How often is medication taken as prescribed? A novel assessment technique
14. The electronic medication event monitor; lessons for pharmacotherapy
15. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
16. A comparison study of multiple measures of adherence to HIV protease inhibitors
17. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials; the AACTG adherence instruments
18. Highly active antiretroviral therapy in a large urban clinic; risk factors for virologic failure and adverse drug reactions
19. Compliance/adherence and care management in HIV disease
20. Problem drinking and medication adherence among persons with HIV infection
21. Adherence to combination antiretroviral therapy assessed by anonymous patient self-report
22. A review of socio-behavioural studies on adherence to antiretroviral treatments; beyond biomedical models?
23. Protease inhibitors in the homeless
24. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
25. Antiretroviral drug resistance testing in adults with HIV infection; implications for clinical management. International AIDS Society-USA Panel
26. Determinants of virological response to antiretroviral therapy; implications for long-term strategies
27. Natural history of HIV-1 cell-free viremia
28. Longitudinal HIV-1 RNA levels in a cohort of homosexual men
29. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort study
30. Veterans with HIV/AIDS Cohort study; baseline results
31. Screening with the alcohol use disorders identification test (AUDIT) in an inner-city population
32. Development of the alcohol use disorders identification test (AUDIT); WHO collaborative project on early detection of persons with harmful alcohol consumption-II
33. Screening for depression in the older adult; criterion validity of the 10-Item Center for Epidemiological Studies Depression Scale (CES-D)
34. Clinical biostatistics LIV. The biostatistics of concordance
35. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
36. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic
37. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
38. A cohort study of drug users' compliance with zidovudine treatment
39. Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy
40. Human Immunodeficiency Virus 1 protease inhibitors in clinical practice